We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

205 hedge funds and large institutions have $691M invested in SANGAMO THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

64% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 47

47% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $10.5M

45% more capital invested

Capital invested by funds: $476M → $691M (+$215M)

8% more funds holding

Funds holding: 190205 (+15)

9.43% less ownership

Funds ownership: 64.16%54.73% (-9.4%)

Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M
Name Holding Trade Value Shares
Change
Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$6.05M -$232K -25,000 -4%
Nordea Investment Management
27
Nordea Investment Management
Sweden
$5.83M +$3.11M +335,542 +103%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.87M +$268K +28,840 +6%
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$4.66M -$1.44M -155,000 -23%
PAM
30
Panagora Asset Management
Massachusetts
$4.18M +$968K +104,326 +29%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$4.13M +$260K +28,063 +6%
Deutsche Bank
32
Deutsche Bank
Germany
$4.04M +$3.15M +339,409 +303%
AGA
33
Altrinsic Global Advisors
Connecticut
$3.73M
B
34
Bailard
California
$3.63M -$427K -46,000 -10%
Macquarie Group
35
Macquarie Group
Australia
$3.62M +$41.9K +4,518 +1%
Morgan Stanley
36
Morgan Stanley
New York
$3.58M +$42.8K +4,618 +1%
CS
37
Candriam SCA
Luxembourg
$3.31M -$1.39M -150,000 -29%
Citadel Advisors
38
Citadel Advisors
Florida
$3.13M -$10.6M -1,141,963 -77%
Barclays
39
Barclays
United Kingdom
$3.02M +$663K +71,481 +27%
Swiss National Bank
40
Swiss National Bank
Switzerland
$2.32M +$315K +33,900 +15%
Citigroup
41
Citigroup
New York
$2.29M +$156K +16,866 +7%
Bank of America
42
Bank of America
North Carolina
$2.18M +$1.42M +153,597 +171%
PIM
43
Platinum Investment Management
Australia
$2.15M -$49.4K -5,328 -2%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$2.09M -$11.1K -1,200 -0.5%
FCM
45
Frontier Capital Management
Massachusetts
$1.96M -$230K -24,798 -10%
PPA
46
Parametric Portfolio Associates
Washington
$1.88M +$366K +39,478 +23%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.74M +$224K +24,186 +14%
State of New Jersey Common Pension Fund D
48
State of New Jersey Common Pension Fund D
New Jersey
$1.7M -$344K -37,132 -16%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.6M +$8.35K +900 +0.5%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.57M +$11K +1,190 +0.7%

SGMO Hedge Fund Activity: Q2 2020 in Review

205 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2020, worth a combined $691M — up 45% from $476M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SGMO positions and 15 closed out — a net gain of 16 holders — while 77 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $14.7M sold.

  • 205 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2020, up from 190 in Q1 2020.
  • Funds reported $691M of SANGAMO THERAPEUTICS INC stock for Q2 2020, up 45% quarter-over-quarter.
  • 31 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2020 and 15 closed out, a net change of +16 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2020 was State Street, an estimated $15.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2020 was EcoR1 Capital, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2020.